Baclofen

巴氯芬

Report date: 2026/05/06 20:02:28
NME

Base Information

Drug NameBaclofen
Drug Alias Nameβ-对氯苯基-γ-氨基丁酸baclofeno氯苯氨丁酸BaclofenumKemstro +[13] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGamma-Aminobutyric Acid B Receptor agonists
TargetsGamma-Aminobutyric Acid B Receptor
Therapy Area/IndicationsDepressive Disorder, MajorAnxiety DisordersAlcohol Drinking +[27] 
Global Approved IndicationsSpasmMuscle Spasticity
Approved Indications in ChinaMuscle Spasticity
Original Approved Country/TerritoryUnited States
Original Approved Date1977/11/22
Country/TerritoryCanadaUnited StatesUkraine +[13] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesNovartis Pharma Ag
China Registration ClassN/A

Develop Information

Active CompaniesDhaka Medical CollegeAmnealUniversity Of Louisville +[6] 
Inactive CompaniesSun Pharma Advanced Research Company LtdStrides Pharma International AgMaastricht University +[29] 
Active IndicationsDepressive Disorder, MajorPelvic PainMyoclonus +[6] 
Inactive IndicationsAnxiety DisordersAlcohol DrinkingTobacco Use Disorder +[21] 

Other Information

ATC CodeM03BX01
Related LinksWikipediaDrugBankKEGG